SEARCH
Covaxin: Phase 3 Trial Data Shared With Expert Panel
NYOOOZ TV
2021-06-22
Views
25
Description
Share / Embed
Download This Video
Report
In March Bharat Biotech released a "first interim analysis" of Phase III trial results, and said it demonstrated 81 per cent interim efficacy in preventing COVID-19.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x825emu" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:02
Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News
02:30
Bharat Biotech submits Covaxin Phase 3 trial data, expert panel meet today
01:49
Covaxin Phase 3 Trial Data: DCGI’s Expert Panel Says Bharat Biotech’s Vaccine 77.8% Effective
01:36
Bharat Biotech's Covaxin Recommended By Expert Panel For Phase II III Trials On 2-18 Year-Olds
00:41
Do I have to consent to data being shared?: Data Sharing
00:25
What can I do if my personal data has been shared illegally?: Data Sharing
12:38
Panel recommends phase 2/3 trials of Covaxin on children
09:12
Expert panel recommends Bharat BioTech's Covaxin for restricted emergency use
01:37
Covaxin recommended by expert panel for Children from 2-18 Years
05:14
Covaxin row: Bypassing phases endangers system, say experts
03:52
Covaxin 77.8% Effective In Phase 3 Trial Data
01:45
Covaxin Phase 3 Interim Trial Data: ৮১ শতাংশ কার্যকারিতা দেখিয়েছে কোভ্যাক্সিন, জানাল ভারত বায়োটেক
